ICBBB conference series held annually to provide an interactive forum for presentation and discussion on Bioscience, Biochemistry and Bioinformatics.
The goal of this conference is to bring together the researchers from academia and industry as well as practitioners to share ideas, problems and solutions relating to the multifaceted aspects Bio-Science and Bio-Technology.
Rice University said Monday, November 26, that it had opened a “full investigation” into the involvement of one of its faculty members in a study that purportedly resulted in the creation of the world’s first babies born with edited DNA.
A Chinese scientist triggered alarm and confusion across the scientific community Monday with the claim that he had edited the DNA of human embryos to create twin girls.
The Nuclear Threat Initiative (NTI) Biosecurity Innovation and Risk Reduction Initiative identifies paths to reduce biological risks, everything from preventing illicit gene synthesis to even exploring insurance incentives.
China is ramping up its regulations on the sharing and export of human genetic resources. Experts say breaching of regulations has been common in the past two decades, and a crackdown is necessary.
The Committee on Foreign Investment in the United States (CFIUS) recently broadened its coverage of biotechnology transactions via new regulations that became effective on November 10, 2018.
A crucial part of the arsenal for shaping the future of gene editing is hiding in plain sight: the patent system. In the past, patents have played an important part in regulating new technologies and research.
This report discusses technologies or categories of technologies that, with further scientific attention and investment could help make the world better prepared and equipped to prevent future infectious disease outbreaks from becoming catastrophic events.
The biohackers are committed to mass producing slaughter-free, cheap cultured meat.